TFAM and ovarian carcinoma: Last, the analysis of the association between the protein level of TFAM and the clinical stage of ovarian cancer based on CPTAC platform had a small sample size, particularly for the analysis involving stage I samples (n = 2), which might cause bias to the outcome obtained in this study.